Browse > Article

Doxorubicin Inhibits the Production of Nitric Oxide by Colorectal Cancer Cells  

Jung, In-Duk (College of Medicine, Konyang University)
Lee, Jang-Soon (College of Medicine, Konyang University)
Yun, Seong-Young (College of Medicine, Konyang University)
Park, Chang-Gyo (College of Medicine, Konyang University)
Han, Jeung-Whan (College of Pharmacy, Sungkyunkwan University)
Lee, Hyang-Woo (College of Pharmacy, Sungkyunkwan University)
Lee, Hoi-Young (College of Medicine, Konyang University)
Publication Information
Archives of Pharmacal Research / v.25, no.5, 2002 , pp. 691-696 More about this Journal
Abstract
Doxorubicin (DOX) is an active and broad spectrum chemotherapeutic agent. Increased inducible nitric oxide synthase (NOS) expression and/or activity have been reported in several human tumors. While the relationship between DOX treatment and the enzymatic activity of endothelial NOS has been well characterized, little is known about the effects of DOX on the expression of iNOS in human cancer cells. In the present study, we characterized the effects of DOX on the nitric oxide (NO) production by colorectal cancer cells, DLD-1. IFN-${\gamma}$/IL-1$\beta$ (CM) increased the production of NO, whereas pretreatment of DOX inhibited the production of NO in response to CM in a dose dependent manner. The increased expressions of iNOS mRNA and protein by CM were completely blocked by DOX without affecting the iNOS mRNA stability. However, DOX activated nuclear factor-kB (NF-kB) in response to CM. Furthermore, the expression of inhibitor kB$\alpha$ was reduced by DOX in a dose dependent manner. Collectively, DOX inhibited the production of NO by DLD-1 cells, which is not linked to well known transcription factor, NF-kB. Therefore, further studies on the possible mechanisms of inhibitory effects of NO production by DOX would be worth pursuing.
Keywords
Colorectal cancer; Doxorubicin; Nitric oxide; ${\kappa}B{\alpha}$; $I_{\kappa}B{\alpha}$;
Citations & Related Records

Times Cited By Web Of Science : 6  (Related Records In Web of Science)
Times Cited By SCOPUS : 6
연도 인용수 순위
1 Ambs, S., Merriam, W.G., Bennett, W.P, Felley-Bosco, E., Ogunfusika, M.O., Oser, S.M., Klein, S., Shields, P.G., Billiar, T.R. and Harris, C.C., Frequent nitric oxide synthase-2 expression in human colorectal adenomas: Implication for tumor angiogenesis and colorectal cancer progression. Cancer Res., 58, 334-341 (1998)   PUBMED
2 Cobbs, C.S., Brenman, J.E., Aldape, K.D., Bredt, D.S. and Israel, M.A., Expression of nitric oxide synthase activity in human central nervous system tumors. Cancer Res., 55, 727-730 (1995)   PUBMED
3 Dupraz, P., Cottet, S., Hamburger, F., Dolci, W, Felley-Bosco, E. and Thorens, B., Dominant negative MyD88 proteins inhibit interleukin-1$\beta$/interferon-$\gamma$-mediated induction of nuclear factor $\kappa$B-dependent nitrite production and apoptosis in b cells. J. Biol. Chem., 275, 37672-37678 (2000)   DOI   ScienceOn
4 Green, L., Wagner, D.A, Glogowski, J., Skipper, P.I., Wishnok, J.S. and Tannenbaum, S.R., Analysis of nitrate, nitrite, and [$^{15}N$] nitrate in biological fluids. Anal. Biochem., 126, 131-138 (1982).   DOI   ScienceOn
5 Ignao, L., Endothelium-derived nitric oxide: actions and properties. FASEB J., 3, 31-36 (1989)   PUBMED
6 Lee, H.Y., Lee, J., Kim, E.J., Han, J.W., Lee, H.W., Kang, Y.J. and Chang, K.C., Inhibition of lipopolysaccharide-induced inducible nitric oxide (iNOS) mRNA expression and nitric oxide production by higenamine in murine peritoneal macrophages. Arch. Pharm. Res., 22, 55-59 (1999)   DOI   ScienceOn
7 Siegert, A, Rosenberg, C., Schmitt, W.D., Denkert, C. and Hauptmann, S., Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumor cell invasion. Br. J. Cancer, 86, 1310-1315 (2002)   DOI   ScienceOn
8 Thanos, D. and Maniatis, T., NF-$\kappa$B: a lesson in family values. Cell, 80, 529-532 (1995)   DOI   PUBMED   ScienceOn
9 Thomsen, L.L., Lawton, F.G., Knowles, R., G., Beesley, J.E., Riveros-Moreno, V and Moncada, S., Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54, 1352-1354 (1994)   PUBMED
10 Xie, K. and Fidler, I.J., Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev., 17, 55-75 (1998)   DOI   ScienceOn
11 Jenkins, D.C., Charles, I.G., Thomsen, 1.1., Moss, D.W., Homes, I.S., Baylis, S.A, Rhodes, P., Westmore, K., Emson, P.A. and Moncada, S., Role of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. U.S.A., 92, 4392-4396 (1995)   DOI   ScienceOn
12 Bian, X., McAllister-Lucas, L.M., Shao, E, Schumacher, K.R., Feng, Z., Porter, A.G., Castle, V.P. and Opipari, A.W.J., NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J. Biol. Chem., 276, 48921-48929 (2001)   DOI   ScienceOn
13 Foo, S. and Nolan, G., NF-$\kappa$B to the rescue. Trends Genet., 15, 229-235 (1999)   DOI   ScienceOn
14 Sherman, P.A, Laubach, V.E., Reep, B.R. and Wood, E.R., Purification and eDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry, 32, 11600-11605 (1993)   DOI   ScienceOn
15 St-Denis, A, Chano, F., Tremblay, P.,St-Pierre,Y. and Descoteaux, A, Protein kinase C-$\alpha$ modulates lipopolysaccharide induced functions in a murine macrophage cell line. J. Biol. Chem., 273, 32787-32792 (1998)   DOI   ScienceOn
16 Jaiswal, M., LaRusso, N.F., Burgart, L.J. and Gores, G.J., Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res., 60, 184-190 (2000)   PUBMED
17 Zagozdzon, R., Giermasz, A, Golab, J., Stoklosa, T., Jalili, A. and Jakobisiak, M., The potentiated antileukemic effects of doxorubicin and interleukin-12 combination are not dependent on nitric oxide production. Cancer Lett., 147, 67-75 (1999)   DOI   PUBMED   ScienceOn
18 Chu, S.C., Marks-Konczalik, J., Wu, H., Banks, T.C. and Moss, J., Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem. Biophys. Res. Commun., 248, 871-878 (1998)   DOI   ScienceOn
19 Inagaki, R., Taniguchi, T., Sakai, T., Hayashi, N., Ishii, Y. and Muramatsu, I., Anticancer drugs inhibit induction of NO synthase in rat in vivo. Gen. Pharmacol., 32, 185-188 (1999)   DOI   ScienceOn
20 Fukumura, D. and Jain, R.K., Role of nitric oxide in angio-genesis and microcirculation in tumors. Cancer Metastasis Rev., 17, 77-89 (1998)   DOI   ScienceOn
21 Ambs, S., Hussain, S.P. and Harris, C.C., Interactive effects of nitric oxide and the p53 tumor suppressor gene in car-cinogenesis and tumor progression. FASEB J., 11, 443-448 (1997)   PUBMED
22 Das, K.C. and White, C.W, Activation of NF-$\kappa$B by antineo-plastic agents. J. Biol. Chem., 272, 14914-14920 (1997)   DOI   ScienceOn
23 Denizot, F. and Lang, R., Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods, 89, 271-277 (1986)   DOI   ScienceOn
24 Singal, P.K. and Iliskovic, N., Doxorubicin-induced cardiomyopathy. N. Engl. J. Med., 339, 900-905 (1998)   DOI   PUBMED   ScienceOn
25 O'Neill, L.A.J., Towards an understanding of the signal transduction pathways for interleukin 1. Biochim Biophys Acta, 1266, 31-44 (1995)   DOI   ScienceOn
26 Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G. and Moncada, S., Nitric oxide syntase activity in human breast cancer. Br. J. Cancer, 72, 41-44 (1995)   DOI   PUBMED   ScienceOn
27 Heitmeier, M.R., Scarim, A.L. and Corbett, J.A, Interferon-$\gamma$ increases the sensitivity of islets of langerhans for inducible nitric oxide synthase expression induced by interleukin 1. J. Biol. Chem., 272, 13697-13704 (1997)   DOI   ScienceOn
28 Kalivendi, S.V., Kotamraju, S., Zhao, H., Joseph, J. and Kalyanaraman, B., Doxorubicin-induced apoptosis associated with increased transcription of endothelial nitric-oxide synthase. Cancer Res., 276, 47266-47276 (2001)
29 Brune, B., von Knethen, A and Sandau, K.B., Nitric oxide and its role in apoptosis. Eur. J. Pharmacol., 351, 261-272 (1998)   DOI   PUBMED   ScienceOn